CRIS Current Research Information System

GELFO, VALERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.727
NA - Nord America 1.468
EU - Europa 1.460
SA - Sud America 97
AF - Africa 90
OC - Oceania 3
Totale 4.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.439
IT - Italia 675
SG - Singapore 485
CN - Cina 458
VN - Vietnam 390
DE - Germania 148
GB - Regno Unito 147
HK - Hong Kong 113
SE - Svezia 78
AT - Austria 77
BR - Brasile 76
FR - Francia 66
IE - Irlanda 66
IN - India 47
NL - Olanda 47
KR - Corea 41
RU - Federazione Russa 37
CI - Costa d'Avorio 36
FI - Finlandia 31
JP - Giappone 31
BG - Bulgaria 22
BD - Bangladesh 21
CA - Canada 21
ID - Indonesia 21
TG - Togo 21
JO - Giordania 19
TH - Thailandia 19
ZA - Sudafrica 18
PH - Filippine 16
AR - Argentina 13
CH - Svizzera 11
MY - Malesia 11
EE - Estonia 10
TW - Taiwan 9
IL - Israele 8
PL - Polonia 8
UA - Ucraina 8
ES - Italia 7
IQ - Iraq 7
MX - Messico 7
TR - Turchia 7
CZ - Repubblica Ceca 6
IR - Iran 6
PK - Pakistan 5
SA - Arabia Saudita 5
EC - Ecuador 4
SC - Seychelles 4
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
LT - Lituania 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
CM - Camerun 2
MA - Marocco 2
PY - Paraguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BB - Barbados 1
DZ - Algeria 1
GR - Grecia 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.845
Salva come PNG Salva come JPEG
Città #
Singapore 347
Bologna 330
Ashburn 205
Chandler 166
Hong Kong 101
Southend 101
Ho Chi Minh City 97
Hanoi 96
Hefei 93
San Jose 86
Santa Clara 75
Vienna 72
Dublin 63
Beijing 51
Boardman 50
Princeton 40
Seattle 40
Redmond 38
Seoul 38
Dallas 37
Abidjan 36
Fairfield 36
Milan 35
Los Angeles 28
Wilmington 28
Lauterbourg 27
Houston 26
Munich 25
Modena 22
Sofia 22
Amsterdam 21
Lomé 21
London 20
Tokyo 20
Amman 19
Helsinki 19
São Paulo 19
Woodbridge 19
Bremen 18
New York 17
Cambridge 16
Haiphong 16
Jakarta 16
Medford 16
Naples 16
Shanghai 15
Nanjing 14
Olalla 13
Berlin 12
Buffalo 12
Council Bluffs 12
Frankfurt am Main 12
Bangkok 11
Nuremberg 11
Orem 11
Westminster 11
Can Tho 10
Florence 10
Montreal 10
Saint Petersburg 10
The Dalles 10
Bern 9
Chicago 9
Da Nang 9
Manila 9
Redondo Beach 9
Ann Arbor 8
Jinan 8
Kuala Selangor 8
Rehovot 8
Rome 8
Shenyang 8
Turku 8
Basingstoke 7
Bengaluru 7
Boydton 7
Cogollo del Cengio 7
Dearborn 7
Marcon 7
Reggio Emilia 7
Toronto 7
Xi'an 7
Düsseldorf 6
Guangzhou 6
Jiaxing 6
Pelhrimov 6
Verona 6
Zhengzhou 6
Brescia 5
Brooklyn 5
Ferrara 5
Forlì 5
Padova 5
Phoenix 5
Prato 5
Stanford 5
Stockholm 5
Turin 5
Tân Tiến 5
Visciano 5
Totale 3.128
Salva come PNG Salva come JPEG
Nome #
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 236
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 224
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 224
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 220
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 217
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 214
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 210
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 203
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 203
Modulation of ERBB signaling from tissue homeostasis to cancer progression 201
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 201
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 196
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 186
A putative role for interleukin 1 pathway in resistance to EGFR blockade 171
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 166
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 161
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 146
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 143
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy 140
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 135
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 123
null 121
null 117
Senescence-associated reprogramming impairs response to EGFR neutralization 116
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 109
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 104
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 94
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 94
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 90
Senescence-associated reprogramming impairs response to EGFR neutralization 83
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 47
null 46
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 13
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 12
Totale 4.966
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022347 11 12 5 11 22 18 6 23 28 25 97 89
2022/2023739 58 76 39 97 62 59 24 78 126 16 44 60
2023/2024332 31 47 16 29 24 89 10 17 11 17 19 22
2024/20251.034 38 123 95 62 109 76 92 61 64 62 98 154
2025/20262.026 174 194 183 143 195 110 214 48 435 161 91 78
Totale 4.966